
### [MONDO:0008733](http://purl.obolibrary.org/obo/MONDO_0008733)
**Label:** familial glucocorticoid deficiency

**Subclasses:** [MONDO:0011826](http://purl.obolibrary.org/obo/MONDO_0011826) (glucocorticoid deficiency 2), [MONDO:0012214](http://purl.obolibrary.org/obo/MONDO_0012214) (GCCD3), [MONDO:0013874](http://purl.obolibrary.org/obo/MONDO_0013874) (glucocorticoid deficiency 4), [MONDO:0008735](http://purl.obolibrary.org/obo/MONDO_0008735) (adrenocortical Unresponsiveness to Acth with postreceptor defect), 

**Mapped go classes:** [GO:0034394](http://purl.obolibrary.org/obo/GO_0034394) (protein localization to cell surface), [GO:0015992](http://purl.obolibrary.org/obo/GO_0015992) (proton transport), [GO:0031780](http://purl.obolibrary.org/obo/GO_0031780) (corticotropin hormone receptor binding), [GO:0042594](http://purl.obolibrary.org/obo/GO_0042594) (response to starvation), [GO:0006740](http://purl.obolibrary.org/obo/GO_0006740) (NADPH regeneration), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0008746](http://purl.obolibrary.org/obo/GO_0008746) (NAD(P)+ transhydrogenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0050873](http://purl.obolibrary.org/obo/GO_0050873) (brown fat cell differentiation), [GO:0051641](http://purl.obolibrary.org/obo/GO_0051641) (cellular localization), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process), [GO:0006112](http://purl.obolibrary.org/obo/GO_0006112) (energy reserve metabolic process), [GO:0030818](http://purl.obolibrary.org/obo/GO_0030818) (negative regulation of cAMP biosynthetic process), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0008750](http://purl.obolibrary.org/obo/GO_0008750) (NAD(P)+ transhydrogenase (AB-specific) activity), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031783](http://purl.obolibrary.org/obo/GO_0031783) (type 5 melanocortin receptor binding), [GO:0070996](http://purl.obolibrary.org/obo/GO_0070996) (type 1 melanocortin receptor binding), [GO:0031781](http://purl.obolibrary.org/obo/GO_0031781) (type 3 melanocortin receptor binding), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0031782](http://purl.obolibrary.org/obo/GO_0031782) (type 4 melanocortin receptor binding), 

**Class expressions from DL-Learner:**

- [GO:0031779](http://purl.obolibrary.org/obo/GO_0031779) (melanocortin receptor binding) 70.83%
- [GO:1900372](http://purl.obolibrary.org/obo/GO_1900372) (negative regulation of purine nucleotide biosynthetic process) 54.17%
- [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis) 54.17%
- [GO:0070996](http://purl.obolibrary.org/obo/GO_0070996) (type 1 melanocortin receptor binding) 54.17%
- [GO:0031783](http://purl.obolibrary.org/obo/GO_0031783) (type 5 melanocortin receptor binding) 54.17%
- [GO:0031782](http://purl.obolibrary.org/obo/GO_0031782) (type 4 melanocortin receptor binding) 54.17%
- [GO:0031781](http://purl.obolibrary.org/obo/GO_0031781) (type 3 melanocortin receptor binding) 54.17%
- [GO:0031780](http://purl.obolibrary.org/obo/GO_0031780) (corticotropin hormone receptor binding) 54.17%
- [GO:0030819](http://purl.obolibrary.org/obo/GO_0030819) (positive regulation of cAMP biosynthetic process) 54.17%
- [GO:0030818](http://purl.obolibrary.org/obo/GO_0030818) (negative regulation of cAMP biosynthetic process) 54.17%
- [GO:0030809](http://purl.obolibrary.org/obo/GO_0030809) (negative regulation of nucleotide biosynthetic process) 54.17%
- [GO:0030803](http://purl.obolibrary.org/obo/GO_0030803) (negative regulation of cyclic nucleotide biosynthetic process) 54.17%
- [GO:0016652](http://purl.obolibrary.org/obo/GO_0016652) (oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor) 54.17%
- [GO:0008750](http://purl.obolibrary.org/obo/GO_0008750) (NAD(P)+ transhydrogenase (AB-specific) activity) 54.17%
- [GO:0008746](http://purl.obolibrary.org/obo/GO_0008746) (NAD(P)+ transhydrogenase activity) 54.17%


